Males | Females | P value | |
Patients, N (%) | 98 (86) | 16 (14) | |
Mean age at diagnosis (years) | 6.2±6.1 | 7.4±4.7 | 0.2 |
First symptom, N (%) | |||
Decreased visual acuity | 24 (25) | 6 (38) | 0.5 |
Strabismus | 33 (34) | 5 (31) | |
Leukocoria | 17 (17) | 2 (13) | |
No symptom | 17 (17) | 2 (13) | |
NA | 7 (7) | 1 (6) | |
Stage, N (%) | |||
≤2B2 | 50 (51) | 9 (56) | 0.6 |
>2B2 | 48 (49) | 7 (44) | |
Telangiectasia extension (clock hours, mean±SD) | 6.2±3.4 | 5.8±4.0 | 0.6 |
Intraretinal exudation extension (clock hours, mean±SD) | 5.0±4.5 | 5.8±4.4 | 0.5 |
Subfoveal nodule at diagnosis, N (%) | 26/63 (40) | 3/10 (30) | 0.7 |
No of laser photocoagulation and/or cryotherapy sessions, N | 5.0±2.7 | 3.7±2.8 | 0.1 |
Mean follow-up (years, mean±SD) | 4.6±4.6 | 5.1±5.8 | 0.8 |
*Among patients with stage 3A1 or less at diagnosis.
NA, not available.